« Back
Home /
EDO-S101

EDO-S101

Item no.	TMO-T3516-2mg
Manufacturer	TargetMol
CASRN	1236199-60-2
Amount	2 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 25 mg 2 mg 50 mg 5 mg
Category	Neuroscience Aging & Neurological Disorders Neural Epigenetics Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Citations	1. Mehrling T, et al. The Alkylating-HDAC Inhibition Fusion Principle: Taking Chemotherapy to the Next Level with the First in Class Molecule EDO-S101. Anticancer Agents Med Chem. 2016;16(1):20-8.
Smiles	CN1C=2C(=CC(N(CCCl)CCCl)=CC2)N=C1CCCCCCC(NO)=O
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	Minomustine,Tinostamustine
Shipping Condition	Cool pack
Available
Manufacturer - Targets	HDAC
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	415.36
Description	EDO-S101 (Tinostamustine) is a pan HDAC inhibitor with IC50 values of 9, 9 and 25 nM for HDAC1, HDAC2 and HDAC3 , respectively.
Pathways	DNA Damage/DNA Repair\|\|\|Chromatin/Epigenetic

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T3516-2mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 2 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question